Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Jul;290(1):88-100.
doi: 10.1111/joim.13246. Epub 2021 Mar 13.

Outcomes of COVID-19-positive acute coronary syndrome patients: A multisource electronic healthcare records study from England

Muhammad Rashid  1   2 , Jianhua Wu  3 , Adam Timmis  4 , Nick Curzen  5 , Sarah Clarke  6 , Azfar Zaman  7 , James Nolan  1   2 , Ahmad Shoaib  1   2 , Mohamed O Mohamed  1 , Mark A de Belder  8 , John Deanfield  9 , Chris P Gale  3   10   11 , Mamas A Mamas  1   2   12
Affiliations
Observational Study

Outcomes of COVID-19-positive acute coronary syndrome patients: A multisource electronic healthcare records study from England

Muhammad Rashid et al. J Intern Med. 2021 Jul.

Abstract

Background: Patients with underlying cardiovascular disease and coronavirus disease 2019 (COVID-19) infection are at increased risk of morbidity and mortality.

Objectives: This study was designed to characterize the presenting profile and outcomes of patients hospitalized with acute coronary syndrome (ACS) and COVID-19 infection.

Methods: This observational cohort study was conducted using multisource data from all acute NHS hospitals in England. All consecutive patients hospitalized with diagnosis of ACS with or without COVID-19 infection between 1 March and 31 May 2020 were included. The primary outcome was in-hospital and 30-day mortality.

Results: A total of 12 958 patients were hospitalized with ACS during the study period, of which 517 (4.0%) were COVID-19-positive and were more likely to present with non-ST-elevation acute myocardial infarction. The COVID-19 ACS group were generally older, Black Asian and Minority ethnicity, more comorbid and had unfavourable presenting clinical characteristics such as elevated cardiac troponin, pulmonary oedema, cardiogenic shock and poor left ventricular systolic function compared with the non-COVID-19 ACS group. They were less likely to receive an invasive coronary angiography (67.7% vs 81.0%), percutaneous coronary intervention (PCI) (30.2% vs 53.9%) and dual antiplatelet medication (76.3% vs 88.0%). After adjusting for all the baseline differences, patients with COVID-19 ACS had higher in-hospital (adjusted odds ratio (aOR): 3.27; 95% confidence interval (CI): 2.41-4.42) and 30-day mortality (aOR: 6.53; 95% CI: 5.1-8.36) compared to patients with the non-COVID-19 ACS.

Conclusion: COVID-19 infection was present in 4% of patients hospitalized with an ACS in England and is associated with lower rates of guideline-recommended treatment and significant mortality hazard.

Keywords: England; acute coronary syndrome; coronavirus disease 2019; mortality; pandemic.

PubMed Disclaimer

Conflict of interest statement

None reported.

Figures

Fig. 1
Fig. 1
Daily cases of COVID‐19 ACS hospitalized during the study period. AMI = acute myocardial infarction, STEMI = ST‐elevation acute myocardial infarction, NSTEMI = non‐ST‐elevation acute myocardial infarction.
Fig. 2
Fig. 2
In‐hospital outcomes and 30‐day mortality of COVID‐19 ACS patient compared with non‐COVID‐19 ACS patients.
Fig. 3
Fig. 3
Independent predictors of 30‐day mortality in COVID‐positive AMI patients.
See this image and copyright information in PMC

References

    1. CSSE J . Coronavirus COVID‐19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). 2020‐03‐15]. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594.... (2020).
    1. Gulati A, Pomeranz C, Qamar Z, Thomas S, Frisch D, George G, et al. A comprehensive review of manifestations of novel coronaviruses in the context of deadly COVID‐19 global pandemic. Am J Med Sci. 2020;360:5–34. - PMC - PubMed
    1. Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID‐19. Nat Med. 2020;26:1017–32. - PMC - PubMed
    1. Montone RA, Iannaccone G, Meucci MC, Gurgoglione F, Niccoli G. Myocardial and microvascular injury due to coronavirus disease 2019. Eur Cardiol. 2020;15:e52. - PMC - PubMed
    1. Bonow RO, Fonarow GC, O'Gara PT, Yancy CW. Association of coronavirus disease 2019 (COVID‐19) with myocardial injury and mortality. JAMA Cardiol. 2020;5:751–3. - PubMed

Publication types